Shares of GSK PLC GSK inched up 0.59% to £13.64 Thursday, on what proved to be an all-around positive trading session for the ...

Wells Fargo (WFC), Goldman Sachs (GS), Citigroup (C), Bank of America (BAC), and Morgan Stanley (MS) all beat estimates, instilling confidence that the Financials sector earned its 28% performance ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Arcos Dorados Holdings Inc. ARCO is a franchisee of McDonald’s restaurants. The Zacks Consensus Estimate for its current year ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

BioVersys is working on producing new antibiotics to tackle antimicrobial-resistant diseases. The IPO will help it take its ...